AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2017
May 9, 2017
284_dirs_2017-05-09_dc636b6b-5759-4487-9c56-150a92b2dd6e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-05-05
Reporting Person: GRADDICK WEIR MIRIAN M (Exe V-P, HR)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-05 | Stock Option (right to buy) | $63.9700 | A | 72753.0000 | Acquired | 2027-05-04 | Common Stock (72753.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 106484.3190 | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8